The Effectivness of probiotic in the treatment ofgastrointestinal symptoms in patients withscleroderma
Not Applicable
- Conditions
- scleroderma.Systemic sclerosis
- Registration Number
- IRCT2015120618142N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
patients with gastrointestinal symptoms moderate to sever
Exclusion criteria: non using drug in exact time; non tolerance for drug side effects; non tended to participate in study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in gastrointestinal symptoms. Timepoint: Baseline-two month late. Method of measurement: Score.
- Secondary Outcome Measures
Name Time Method Improvment in reflux condition , emotional and social function. Timepoint: baseline-after two months. Method of measurement: Score.